SORIA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 6.251
AS - Asia 2.836
EU - Europa 2.602
SA - Sud America 493
Continente sconosciuto - Info sul continente non disponibili 285
AF - Africa 77
OC - Oceania 6
Totale 12.550
Nazione #
US - Stati Uniti d'America 5.946
SG - Singapore 963
IT - Italia 733
CN - Cina 496
VN - Vietnam 443
HK - Hong Kong 385
BR - Brasile 370
DE - Germania 359
RU - Federazione Russa 335
SE - Svezia 283
CA - Canada 228
IE - Irlanda 205
FR - Francia 163
GB - Regno Unito 151
IN - India 101
BD - Bangladesh 96
UA - Ucraina 68
ID - Indonesia 53
IQ - Iraq 48
AT - Austria 47
FI - Finlandia 46
NL - Olanda 45
TR - Turchia 43
AR - Argentina 36
JP - Giappone 34
MX - Messico 33
DK - Danimarca 30
CO - Colombia 29
PL - Polonia 29
ES - Italia 28
ZA - Sudafrica 26
PK - Pakistan 22
KR - Corea 19
SA - Arabia Saudita 19
PH - Filippine 17
EC - Ecuador 16
BE - Belgio 13
UZ - Uzbekistan 12
JM - Giamaica 11
KE - Kenya 11
VE - Venezuela 11
CH - Svizzera 10
CL - Cile 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
IR - Iran 9
MY - Malesia 9
CZ - Repubblica Ceca 8
LT - Lituania 8
OM - Oman 8
DZ - Algeria 7
MA - Marocco 7
BG - Bulgaria 6
GR - Grecia 6
IL - Israele 6
PE - Perù 6
PY - Paraguay 6
SN - Senegal 6
TT - Trinidad e Tobago 6
EG - Egitto 5
JO - Giordania 5
PT - Portogallo 5
TH - Thailandia 5
UY - Uruguay 5
AU - Australia 4
EU - Europa 4
HU - Ungheria 4
LB - Libano 4
NI - Nicaragua 4
NP - Nepal 4
PA - Panama 4
RO - Romania 4
TN - Tunisia 4
AZ - Azerbaigian 3
BO - Bolivia 3
EE - Estonia 3
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
KZ - Kazakistan 3
MD - Moldavia 3
SY - Repubblica araba siriana 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
BY - Bielorussia 2
GE - Georgia 2
KG - Kirghizistan 2
LY - Libia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RS - Serbia 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BZ - Belize 1
CI - Costa d'Avorio 1
Totale 12.257
Città #
Ann Arbor 894
Singapore 546
Ashburn 524
San Jose 431
Hong Kong 375
Frankfurt am Main 257
Chandler 244
Fairfield 225
Dublin 200
New York 189
Milan 172
Council Bluffs 163
Toronto 156
Wilmington 150
Houston 124
Ho Chi Minh City 123
Los Angeles 122
Hanoi 119
Woodbridge 111
Dallas 100
Chicago 97
Seattle 97
Santa Clara 95
Beijing 92
Paris 83
Princeton 72
Cambridge 70
Rome 59
Jacksonville 52
The Dalles 50
Hefei 46
Buffalo 44
Jakarta 43
São Paulo 40
Lauterbourg 38
Altamura 37
Dearborn 36
Columbus 35
Vienna 34
Lawrence 33
Moscow 33
Shanghai 31
Atlanta 28
Boardman 27
London 27
Phoenix 27
Tokyo 27
Denver 25
Pune 23
Brooklyn 22
Guangzhou 22
Orem 22
Baghdad 21
Bologna 21
Haiphong 21
Helsinki 21
Montreal 21
Warsaw 21
Johannesburg 20
Nanjing 20
Nuremberg 19
Seoul 19
Stockholm 19
Amsterdam 18
Poplar 18
Andover 17
Boston 17
Fremont 17
Bogotá 16
Munich 15
San Diego 15
Dong Ket 14
Ottawa 14
Lappeenranta 13
Salt Lake City 13
Brussels 12
Philadelphia 12
Washington 12
Da Nang 11
Figino 11
Nairobi 11
Rio de Janeiro 11
Tashkent 11
Turin 11
Changsha 10
Manchester 10
Thái Nguyên 10
Charlotte 9
Chennai 9
Hangzhou 9
Hải Dương 9
Jeddah 9
Kingston 9
Lachine 9
Quận Bình Thạnh 9
Biên Hòa 8
Catania 8
Falls Church 8
Mexico City 8
Newark 8
Totale 7.346
Nome #
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 631
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 559
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 439
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 398
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 393
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 384
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 365
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 365
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 364
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 362
HIV testing: A must for patients with inflammatory bowel disease 339
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 337
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 336
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 335
High rates of 30-day mortality in patients with cirrhosis and COVID-19 327
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 325
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 309
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 303
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 302
Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests 295
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 275
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 269
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 261
Unmasking tuberculosis in the era of antiretroviral treatment 260
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 260
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 258
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 258
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 256
Knowledge, Use, and Misuse of Self-Prescribed Doxycycline Postexposure Prophylaxis in a Community-Based Preexposure Prophylaxis Service 251
Beware of biases in observational studies on anti-spike monoclonal antibodies 242
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 230
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 228
COVID-19 Infection among Incarcerated Individuals and Prison Staff in Lombardy, Italy, March 2020 to February 2021 216
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition 206
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 196
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 191
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 184
Imported ciprofloxacin-resistant Neisseria meningitidis 184
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study 169
Pharmacotherapy of HIV: Focus on Etravirine 161
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study 138
Unexpected viral relapses in hepatitis C virus–infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals 131
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 115
Reply 74
Reply 69
Totale 12.550
Categoria #
all - tutte 39.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.799


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022468 0 0 0 80 33 73 8 33 18 59 60 104
2022/20231.042 107 310 106 97 52 151 17 74 63 9 38 18
2023/2024711 26 18 30 24 100 222 126 34 36 19 8 68
2024/20251.995 84 189 128 79 155 92 141 66 154 258 140 509
2025/20264.676 503 204 318 498 545 226 647 171 292 386 269 617
2026/20271.300 174 225 424 477 0 0 0 0 0 0 0 0
Totale 12.550